TREM2 and fatty liver disease: Prior rodent experiments have evidenced that the TREM2+ Macs counterparts emerged in fatty liver, acne lesions, and tumors originating from recruited circulating monocytes.[24, 25] Our trajectory also suggested a differentiation potential from monocyte to TREM2+ Macs.